secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-06-29T20:15:37+00:00
Accession:  0001193125-26-288468
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics closes $3M private placement; warrants could add $6M
-------------------------------------------------------------------

- Gross proceeds of $3.0M from sale of 4.08M shares/pre-funded warrants + warrants at $0.735/share.
- Net proceeds ~$2.6M; warrants exercisable only after stockholder approval for up to 8.16M additional shares.
- If all warrants exercised for cash, total gross proceeds could reach ~$9.0M.
- H.C. Wainwright acted as placement agent, receiving 7% cash fee and 285,714 placement agent warrants.
- Funds earmarked for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526288468/0001193125-26-288468-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526288468/fblg-20260625.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-288468

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer